We are live on
!
Find out more
Polen Capital Management Portfolio holdings
AUM
$11.6B
1-Year Est. Return
8.03%
This Fund
S&P 500
This Quarter
Est. Return
+6.01%
1 Year Est. Return
+8.03%
3 Year Est. Return
+64.37%
5 Year Est. Return
+58.48%
10 Year Est. Return
+511%
AUM
$30.8B
AUM Growth
-$1.78B
(-5.5%)
Cap. Flow
-$2.86B
Cap. Flow
% of AUM
-9.3%
Top 10 Holdings %
Top 10 Hldgs %
56.46%
Holding
292
New
52
Increased
67
Reduced
112
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$1.09B |
| 3 |
Synopsys
SNPS
|
+$591M |
| 4 |
Boston Scientific
BSX
|
+$580M |
| 5 |
Intuit
INTU
|
+$477M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$966M |
| 2 |
Oracle
ORCL
|
+$686M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Adobe
ADBE
|
+$538M |
| 5 |
Shopify
SHOP
|
+$492M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 46.94% |
| 2 | Financials | 16.15% |
| 3 | Healthcare | 15.52% |
| 4 | Consumer Discretionary | 12.62% |
| 5 | Communication Services | 5.99% |
Similar funds
HTC
BMSSC
AI
AAIS
QC
MIF
RI
RCM
Polen Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Polen Capital Management held 292 positions worth $30.8B, down 5.5% from $32.6B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Polen Capital Management withdrew a net $2.86B in Q3 2025, closing 60 positions and reducing 112 holdings. Its most notable exit was Novo Nordisk, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 39% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Polen Capital Management opened a new position in Broadcom worth $1.48B.
- Polen Capital Management's largest Q3 2025 buy was Broadcom: 4,485,854 shares worth $1.48B.
- Polen Capital Management added most to NVIDIA in Q3 2025, an estimated $1.09B increase.
- Polen Capital Management's biggest Q3 2025 reduction was Thermo Fisher Scientific, cutting an estimated $966M.
- Polen Capital Management fully exited Novo Nordisk in Q3 2025, selling an estimated $12.3M.
- Polen Capital Management's ten largest holdings make up 56% of its $30.8B portfolio in Q3 2025.
- Polen Capital Management opened 52 new positions and closed 60 in Q3 2025.
- Polen Capital Management's portfolio value fell 5.5% quarter-over-quarter to $30.8B.
Based on Polen Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.